Clostridium Difficile Infection (CDI)
6 clinical trials · Condition
◉ Watch Clostridium Difficile Infection (CDI)
| Record | Firm | Date |
|---|---|---|
| Study of Metronidazole Delayed-Release Capsules in Comparison With Immediate-Release Tablets (Flagyl) for Safety and Pharmacokinetics (NCT07251127) | Gateway Pharmaceutical LLC | 2025-05-27 |
| Treatment of Mild-moderate Clostridium Difficile Infection (CDI) (NCT04121169) | ImmuniMed Inc. | 2019-10-04 |
| Evaluation of Fidaxomicin in the Treatment of Clostridium Difficile Infection (CDI) (NCT04070352) | University of Pittsburgh | 2019-08-01 |
| Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3) (NCT03244644) | Rebiotix Inc. | 2017-07-31 |
| A Comparison of Fidaxomicin and Vancomycin in Patients With CDI Receiving Antibiotics for Concurrent Infections (NCT02692651) | University of Michigan | 2017-05-01 |
| Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI) (NCT02437591) | Astellas Pharma Europe Ltd. | 2015-08-13 |
Track Clostridium Difficile Infection (CDI) automatically
Every clearance here is in the API, with alerts when new ones post.